Case Details

Last Update: 7/16/2026 12:29 AM PDT « Back to List View

Please note that only previously-scheduled plaintiff and expert depositions are posted on this "Case List" page. To view future Plaintiff and Expert Deposition activity please visit Plaintiff Depos or Expert Depos pages. Alternatively, view future plaintiff depositions for this case or future expert depositions for this case

Case Name:
FARAHMAND, MEHRAK V. CHANEL, INC.
Docket:
ACSC 25CV162519
Plaintiff’s Attorney:
KAZAN
Trial Group:
Disease Category:
MZ
SSC/CMC Date:
7/23/2026 - Case Management Conference
Date Time Location Event Type/Activity Details
1/30/2026 (ROP1) Date of receipt of Ans. to Interrog. Set 1.
7/16/2026 3:00 PM #18 PLAINTIFF'S MOTION Plfs Ex Parte Application for an order to file a single consolidated reply brief of no more than 20 pages in support of Plaintiffs’ Motion for Trial ` Preference, which is set for hearing on July 23, 2026. (per 7/15 efile #80036298).zb
7/23/2026 1:30 PM #18 Case Management Conference CMC - CONT'D fr. 6/30 CMC. CMS due 7 days prior. (per 6/30 results fr. EMS).zb
7/23/2026 1:30 PM #18 MOTION TO ADVANCE CCP 36(D) Kazan/Plfs Motion for Trial Preference pursuant to C.C.P. 36(d) (e). (per 6/22 efiled mvg pprs #79844317).zb (EL and ELC, Clinique Laboratories, LLC, and M.A.C. Cosmetics, Inc. OPP) (Tarte, Inc., Shiseido Americas Corporation and Orveon Global US OPP) (CVS PHARMACY, INC.; WALGREEN CO.; SAFEWAY INC.; THE VONS COMPANIES, INC.; AND LONGS DRUG STORES CALIFORNIA OPP)